Source: Biohit Oyj
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10
Biohit Oyj
STOCK EXCHANGE RELEASE
June 8, 2018 at 3.30 PM
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
Biohit Oyj has received an announcement from Biohit Healthcare (Hefei) Co., Ltd on June (city and country of residence: Hefei, Anhui, Peoples Republic of China) 8, 2018 in accordance with the Finnish Securities Market Act Chapter 9, Section 5.
According to the announcement, the total number of Biohit Oyj shares owned by Biohit Healthcare (Hefei) Co., Ltd has increased over thirty (30) per cent of the share capital of Biohit Oyj and total number of Biohit Oyj voting rights owned by Biohit Healthcare (Hefei) Co., Ltd has increased over twenty five (25) per cent of all voting rights on June 8, 2018.
Total positions of Biohit Healthcare (Hefei) Co., Ltd according to the notification:
| % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both in % | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which the threshold was crossed or reached | 33.2 % of shares and 29.5 % of voting rights | 14,889,278 shares and 71,423,778 votes | ||
| Position of previous notification (if applicable) |
Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: shares and voting rights:
| Class / type of shares ISIN-code | Number of shares and voting rights | % of shares and voting rights | ||
| Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 ja 9:7) | |
| A-shares | 850,000 | 5,7 % of shares and 23,8 % of votes | ||
| B-shares | 4,095,415 | 27,5 % of shares and 5,7 % of votes | ||
| SUBTOTAL A | 4,945,415 shares and 21,095,415 votes | 33.2 % of shares and 29.5 % of votes | ||
B: Financial instruments according to SMA 9:6a
| Type of Financial instrument | Expiration date | Exercise / Conversion period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
| SUBTOTAL B | |||||
Information on the party obliged to give notice of major shareholding:
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:
| Name | % of shares and voting rights | % of shares and voting rights through financial instruments | Total of both | ||
| Liu Feng | 55.7143 | % | 55.7143 | % | |
More information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi, www.biohit .fi
Biohit Oyj in brief
Biohit Oyj is a Finnish biotechnology company operating on a global scale. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit’s headquarters are located in Helsinki with subsidiaries in Italy and the UK.